StockMarketWire.com - UBS today reaffirms its sell investment rating on Synthomer [LON:SYNT] and raised its price target to 350p (from 340p).

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk